Group A Streptococcus vulvovaginitis in Spain, 2011–2023: antibiotic resistance and emm-type distribution

Elena Sánchez-Báscones,Alba Bellés-Bellés,Pilar Villalón Panzano,Noelia Garrido Castrillo,Andrea Castellano Verdasco,Albert Bernet Sánchez,Saray Mormeneo Bayo,Eric López González,Iván Prats Sánchez,Mercè García-González
DOI: https://doi.org/10.1007/s10096-024-04971-z
2024-11-02
European Journal of Clinical Microbiology & Infectious Diseases
Abstract:An increase in Group A Streptococcus vulvovaginitis was detected in 2023: The average number of cases per year was 13 during 2011–2017. Twenty-five and 27 cases were reported in 2018 and 2019 followed by a decline coinciding with the COVID-19 pandemic. The 2023 increase surpassed previous data. The most frequent resistances were to erythromycin (11.3%;) and tetracycline (8.8%). Eleven different emm -types were detected among 30 GAS isolated in 2023: emm 1 was predominant (36.7%) followed by emm 89 (20%), emm 87 (10%) and emm 28 (6.7%). GAS should be increasingly considered in women with vulvovaginitis.
infectious diseases,microbiology
What problem does this paper attempt to address?